Glaucoma Related Quality of Life

Part of paid clinical trials in Iowa City, Iowa.

Sponsor
Marc Toeteberg-Harms
Study ID
NCT07510087
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • GQL-15 — OTHER
    GQL-15 questionnaire
  • Glaucoma Symptom Scale — OTHER
    GSS questionnaire
  • NEI Vision Function Questionnaire — OTHER
    Vision function questionnaire
  • Ocular Surface Disease Index — OTHER
    OSDI questionnaire

Study Details

Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.

Key Dates

First listed
Apr 3, 2026
Start date
Dec 30, 2024
Status verified
Apr 2026
Primary completion
Nov 30, 2026
Completion
May 30, 2027

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Study Arm (glaucoma)
    subjects with a diagnosis of glaucoma

Primary Outcome Measure

Ocular Surface Disease Index (OSDI) [ Time Frame: At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Iowa, Dept. of Ophthalmology & Visual SciencesIowa CityIowa52242
Marc Toeteberg-Harms, MD
[email protected]
+1 319 356 3938
Helen Gomez
[email protected]
+1 319 356 3938
Marc Toeteberg-Harms, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Iowa City, IA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
University of Iowa, Dept. of Ophthalmology & Visual Sciences· Iowa City, IA

Related Studies